Thousands of men are set to benefit from a new prostate cancer drug which has been approved for use on the NHS.
Full ArticleThousands of men to benefit from new prostate cancer drug approved for use on NHS
Sky News
0 shares
4 views
You might like
Related news coverage
Noxopharm a rare COVID-19 beneficiary with ‘versatile and valuable’ technology platform, says CEO
Noxopharm Ltd (ASX:NOX) chief executive officer and managing director Dr Graham Kelly has highlighted the company’s achievements..
Proactive Investors
Noxopharm set to benefit from new data showing experimental drug Lu-PSMA-617 to become important treatment for late-stage prostate cancer
Noxopharm Ltd (ASX:NOX) welcomes news that Novartis' experimental drug, 177Lutetium-PSMA-617 (Lu-PSMA-617), looks set to become..
Proactive Investors